Skip to main content

Table 1 Effect of DA-9401 on body, reproductive organ weight, serum hormone concentration, sperm count, motility, and fertility parameters in adriamycin treated male SD rats

From: Cross-talk between ER stress and mitochondrial pathway mediated adriamycin-induced testicular toxicity and DA-9401 modulate adriamycin-induced apoptosis in Sprague–Dawley rats

Parameter

CTR

DA 100

ADR

ADR + DA 100

ADR + DA 200

Body and organ weight

 Body weight (beginning; gm)

229.00 ± 3.97

225.10 ± 3.41

235.91 ± 3.66

239.22 ± 5.37

232.00 ± 2.10

 Body weight (sacrifice; gm)

413.40 ± 9.12

409.20 ± 9.15

320.80 ± 7.94*#

369.88 ± 13.61*#+

341.50 ± 7.98*

 Testis weight (gm)

2.03 ± 0.05

2.06 ± 0.02

0.81 ± 0.05*#

0.91 ± 0.03*#

1.14 ± 0.12*+

 Epididymis weight (gm)

0.72 ± 0.14

0.71 ± 0.01

0.48 ± 0.02*#

0.59 ± 0.02*#+

0.56 ± 0.03*+

 Seminal vesicles weight (gm)

1.34 ± 0.04

1.45 ± 0.05

0.66 ± 0.06*#

1.03 ± 0.08*#+

0.94 ± 0.07*+

 Prostate weight (gm)

0.97 ± 0.05

1.16 ± 0.07

0.67 ± 0.05*#

0.90 ± 0.04#+

0.66 ± 0.04*$

 Penis weight (gm)

0.31 ± 0.01

0.31 ± 0.01

0.26 ± 0.01*#

0.30 ± 0.01+

0.28 ± 0.01

Serum hormone levels

 Serum testosterone (ng/ml)

5.36 ± 0.96

5.53 ± 0.58

0.42 ± 0.07*#

1.62 ± 0.13*#

2.75 ± 0.51*+

 Serum LH (mIU/ml)

39.10 ± 4.07

46.17 ± 2.41

101.26 ± 8.67*#

84.33 ± 11.60*#

88.27 ± 10.62*

 Serum FSH (ng/ml)

4.07 ± 0.58

4.57 ± 0.88

14.30 ± 1.68*#

4.41 ± 1.85+

4.41 ± 0.23+

Sperm count and motility

 Sperm count (106/ml)

  Vas deference

29.14 ± 0.99

26.64 ± 1.82

17.35 ± 0.89*#

22.42 ± 0.79*#+

22.28 ± 0.28*+

  Epididymis

37.78 ± 1.28

34.78 ± 0.79

10.42 ± 2.01*#

16.85 ± 0.96*#+

18.28 ± 1.64*+

 Sperm motility (%)

  Vas deference

65.72 ± 3.06

60.60 ± 4.67

31.50 ± 2.12*#

48.13 ± 2.72*+

39.99 ± 1.85*

  Epididymis

36.78 ± 1.45

38.92 ± 2.19

15.33 ± 1.71*#

26.55 ± 1.65*#+

22.57 ± 1.50*+

Fertility parameters

 Fertility rate (%)

100

100

50*#

80

100+

 Pups per female

12.80 ± 0.78

11.90 ± 0.56

5.60 ± 1.96*#

9.3 ± 1.78

10.50 ± 0.85+

  1. Results are expressed as mean ± SEM
  2. CTR, control; DA 100, DA-9401 100 mg/kg/day p.o.; ADR, adriamycin 2 mg/kg i.p. per week; ADR + DA 100, adriamycin 2 mg/kg i.p. per week + DA-9401 100 mg/kg/day p.o.; ADR + DA 200, adriamycin 2 mg/kg i.p. per week + DA-9401 200 mg/kg/day p.o. LH, luteinizing hormone; FSH, follicle stimulating hormone; p.o., per oral; i.p., intraperitoneally
  3. *P < 0.05 vs. CTR group, #P < 0.05 vs. DA 100 group, +P < 0.05 vs. ADR group, $P < 0.05 vs. ADR + DA 100 group (one-way ANOVA followed by the Tukey post hoc test; n = 10 for each group)